Cosmetic cross-reference Noindex: medium evidence

Benzoic Acid 4-Methylphenyl Ester

CAS 614-34-6

Benzoic Acid 4-Methylphenyl Ester (CAS 614-34-6) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Benzoic Acid 4-Methylphenyl Ester
CAS Number
614-34-6
UNII
TRF6AI5R4X
InChIKey
LLRZUDIHEZXFGV-UHFFFAOYSA-N
ChEMBL ID
CHEMBL2260449
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Benzoic Acid 4-Methylphenyl Ester used for in pharmaceutical contexts?

Benzoic Acid 4-Methylphenyl Ester (CAS 614-34-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Benzoic Acid 4-Methylphenyl Ester?

No adverse-event association or SIDER side-effect rows are rendered for Benzoic Acid 4-Methylphenyl Ester in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Benzoic Acid 4-Methylphenyl Ester also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for p-Cresyl Benzoate with EU status "permitted".

What clinical phase is Benzoic Acid 4-Methylphenyl Ester in?

No phase 1-4 clinical development badge is rendered for Benzoic Acid 4-Methylphenyl Ester because the matched compound identifier rows do not contain a max-phase value.